Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 16, 2015
[Current Cancer Immunotherapy Using Activated Lymphocytes - Do Lymphocytes Actually Recognize Cancer Cells ?]
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research
|
November 11, 2006
Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432
Katsuji Hironaka, Yoshiyuki Yamaguchi, Riki Okita, et al.
Anticancer Research
|
January 30, 2022
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients With Incurable Pancreatic Cancer
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research
|
April 30, 2016
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Hiroshima Journal of Medical Sciences
|
June 27, 2008
Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion
Makoto Okawaki, Yoshiyuki Yamaguchi, Riki Okita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 26, 2018
[Introduction]
Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Molecular and Clinical Oncology
|
December 9, 2021
Erratum: Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
Yoshiyuki Yamaguchi, Yousuke Katata, Fuminori Sano, et al.
Molecular and Clinical Oncology
|
September 9, 2020
Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
Yoshiyuki Yamaguchi, Yousuke Katata, Fuminori Sano, et al.
Anticancer Research
|
May 5, 2005
HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab
Yoshiyuki Yamaguchi, Katsuji Hironaka, Makoto Okawaki, et al.
Cancer Diagnosis & Prognosis
|
July 5, 2023
Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer
Yoshiyuki Miyaji, Kazuo Nakanishi, Akira Yamamoto, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 16, 2015
[Current Cancer Immunotherapy Using Activated Lymphocytes - Do Lymphocytes Actually Recognize Cancer Cells ?]
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research
|
November 11, 2006
Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432
Katsuji Hironaka, Yoshiyuki Yamaguchi, Riki Okita, et al.
Anticancer Research
|
January 30, 2022
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients With Incurable Pancreatic Cancer
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Anticancer Research
|
April 30, 2016
A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer
Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, et al.
Hiroshima Journal of Medical Sciences
|
June 27, 2008
Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion
Makoto Okawaki, Yoshiyuki Yamaguchi, Riki Okita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 26, 2018
[Introduction]
Yoshiyuki Yamaguchi, Yosuke Katata, Makoto Okawaki, et al.
Molecular and Clinical Oncology
|
December 9, 2021
Erratum: Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
Yoshiyuki Yamaguchi, Yousuke Katata, Fuminori Sano, et al.
Molecular and Clinical Oncology
|
September 9, 2020
Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
Yoshiyuki Yamaguchi, Yousuke Katata, Fuminori Sano, et al.
Anticancer Research
|
May 5, 2005
HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab
Yoshiyuki Yamaguchi, Katsuji Hironaka, Makoto Okawaki, et al.
Cancer Diagnosis & Prognosis
|
July 5, 2023
Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer
Yoshiyuki Miyaji, Kazuo Nakanishi, Akira Yamamoto, et al.
Page
of 3